EU_Haem_contents.qxp 14/3/08 16:16 Page 3
Contents
Transfusion
Current and Future Alternatives for Allogeneic Blood Product Transfusions 32
Christopher A Tormey,
1
Michelle L Erickson
1
and YanYun Wu
2
1. Fellow, Transfusion Medicine, Department of Laboratory Medicine, Yale-New Haven Hospital;
2. Assistant Professor, Department of Laboratory Medicine, Yale University School of Medicine, and
Assistant Director, Blood Bank and Apheresis/Transfusion Service, Yale-New Haven Hospital, Connecticut
Intravenous Rhesus Immune Globulin and Intravenous Immunoglobulin in
Immune Thrombocytopenic Purpura 37
James Bussel,
1
Michael D Tarantino,
2
Luba Nalysnyk,
3
Kyle Fahrbach,
3
Brian Sercus,
3
Maurice Genereux
4
and Chris Sinclair
4
1. Department of Pediatrics, Weill Medical College of Cornell University, New York;
2. Comprehensive Bleeding Disorders Center, University of Illinois College of Medicine;
3. United BioSource Corporation, Medford; 4. Cangene Corporation, Winnipeg
Transplantation
Advances in Preventing Cytomegalovirus Disease in Stem Cell Transplant Recipients 44
Karen K Biron
1
and Per Ljungman
2
1. Past President, International Society for Antiviral Research (ISAR);
2. Past President and Secretary, European Group for Blood and Marrow Transplantation (EBMT)
Modulating the Interaction of Stromal-cell-derived Factor-1/CXCL12 and its
Receptor, CXCR4, for Enhanced Mobilisation, Homing and Engraftment of
Haematopoietic Stem Cells 47
Hal E Broxmeyer and Timothy B Campbell
Department of Microbiology and Immunology, and the Walther Oncology Center, Indiana University School of Medicine
Thrombosis and Haemostasis
‘Traveller’s Thrombosis’ – Does It Exist and Are We Ready to Give Prophylaxis? 50
Frits R Rosendaal
Chairman, Departments of Clinical Epidemiology and Thrombosis and Haemostasis,
Leiden University Medical Centre
Venous Thromboembolism – The Intersection of Thrombosis and Inflammation 52
Thomas W Wakefield and Daniel D Myers, Jr
Section of Vascular Surgery, Department of Surgery, University of Michigan
Anaemia and Haemaglobinopathies
Thalassaemia – A Comparative Analysis Across Europe 55
Androulla Eleftheriou
Executive Director, Thalassaemia International Federation, Nicosia
Rituximab Therapy for Immune Anaemia and Thrombocytopenia 56
Daan Dierickx
1
and André Delannoy
2
1. Department of Haematology, University Hospital Gasthuisberg, Leuven;
2. Department of Haematology, Hôpital de Jolimont, Haine-Saint-Paul
The Biology of Fanconi Anaemia 59
Gary M Kupfer and Gang Zhi
Department of Pediatrics, Yale University School of Medicine, New Haven
Infection in Haematology
Helicobacter pylori and Idiopathic Thrombocytopenic Purpura – Where Do We Stand? 62
Roberto Stasi
Department of Medical Sciences, Ospedale Regina Apostolorum, Albano Laziale, Rome
EUROPEAN HAEMATOLOGY 2007 3
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66